5
Views
0
CrossRef citations to date
0
Altmetric
Research Article

LITERATURE ALERTS

Pages 261-272 | Published online: 29 Sep 2008

References

  • 1H NMR spectroscopic studies of the interaction of thymol with phospholipid liposomes. FUJISAWA, S., and KADOMA, Y. Dent. Mater. J., 1998, 17 (2), 139–147.
  • A computer-based expert system designs and analyzes a 2(k -p)fractional factorial design for the formulation optimization of novel multicomponent liposomes. LOUKAS, Y. L. Pharm. Biomed. Anal., 1998, 17 (1), 133–140.
  • A proposed new method for the crosslinking of chitosan microspheres. Cori, B., MODINA, T., GENTA, I., PERUGINI, P., and PAVANETTO, F. Drug Delivery, 1998, 5 (2), 87–93.
  • A simple and rapid high-performance liquid chromatography method to quantify and evaluate the purity of nicotine in solution and in microspheres. GUDET, A. L. C., and BuRi, P. S TP Pharma. ScL, 1998,8 (2), 139–144.
  • Activation of macrophages from lymphoma-bearing mice by liposome mediated intraper-itoneal interleukin 2 (IL-2) and IL-6 gene therapy. WANG, Q., Co, X., WANG, J., ZHANG, W., MA, S., and YE, T. Zhonghua Xueyexue Zazhi, 1997, 18 (7), 364–367.
  • Adhesive interactions of liposomes with supported planar bilayers on QCM as a new adhesion model. LIEBAU, M., BENDAS, G., ROTHE, U., NEUBERT, R. H. H. Sens. Actuators, B, 1998, B47 (1–3), 239–245.
  • Administration of liposom al agents and blood clearance capacity of the mononuclear phagocyte system. VAN ETTEN, E. W. M., TEN, K. M. T., SNIJDERS, S. V., and BAKKER, W. I. A. J. M. Antimicrob. Agents Chemother., 1998, 42 (7), 1677–1681.
  • Affinity of antioxidative polyphenols for lipid bilayers evaluated with a liposome system. NAKAYAMA, T., ONO, K., and HASHIMOTO, K. BioscL, BiotechnoL, Biochem., 1998, 62 (5), 1005–1007.
  • An adhesion theory for microspheres. BRACH, R. M., Li, X., and Du, P. F. 1998, Proc. Annu. Meet. Adhes. Soc., 21st, 293–295.
  • An engineering model to characterize oxygen transfer rates for liposome encapsulated hemoglobin (LEH). CHUNG, T. W., and PENG, I. H. Artif. Cells Blood Substit. ImrnobiL Biotechnol., 1998, 26 (4), 389–398.
  • Anionic saccharides activate liposomes containing phospholipids bearing a boronic acid for Ca2+ -dependent fusion. ZHANG, Z. Y., and SMITH, B. D. 1998, J. Am. Chem. Soc., 120 (28), 7141–7142.
  • Anti-proliferative effects on human colon cancer cells of combined treatment with cationic liposome-entrapped human interferon-13 or -y gene and anti-cancer drug. SHimizu, M., AKIYAMA, S., ITO, K., KASAI, Y., TAKAGI, H., KITO, M., OHISHI, N., and YAGI, K.Clin.Biochem. Nutr., 1997, 23 (2), 77–83.
  • Antigen-releasing polymer rings and microspheres stimulate mucosal immunity in the vagina. WYATT, T. L., WHALEY, K. J., CONE, R. A., and SALTZMAN, W. M. J. Controlled Release, 1998, 50 (1-3), 93–102.
  • Antioxidant activities of isoflavones and their biological metabolites in a liposom al system. AuonA, A., NAIR, M. G., and STRASBURG, G. M. Arch. Biochem. Biophys., 1998,356(2), 133–141.
  • Antioxidant and pro-oxidant effects of epinephrine and isoprenaline on peroxidation of LDL and lipid liposomes. ONDRIAS, K., STASKO, A., GERGEL, D., HROMADOVA, M., and MISIK, V. PhysioL Res. (Prague), 1998, 47 (2), 119–124.
  • Application of powder coal ash-glass microspheres in polypropylene. ZHENG, Y. Fuzhou Daxue Xuebao, Ziran Kexueban, 1998, 26 (2), 87–90.
  • Assembly of polymer microspheres and the thin-film micropatterning. Du, H., QIAN, X. M., Li, W. M., Liu, F. Q., TANG, J., TANG, X Y BAI, Y. B., and LI, T. J. Mater. Res. Soc. Symp. Proc., 1998, 501 (Surface-Controlled Nanoscale Materials for High-Added-Value Applications), 221–226.
  • Atomic force microscopy used for the surface characterization of microcapsule immuno-isolation devices. Xu, K., HERCULES, D. M., LAcix, I., and WANG, T. G. J. Biomed. Mater. Res., 1998, 41 (3), 461–467.
  • Bioadhesive liposomes bearing levonorgestrel as controlled drug delivery system. UPPADHYAY, A. K., and DIXIT, V. K. Pharmazie, 1998, 53 (6), 421–422.
  • Bioavailability, absorption mechanism, and toxicity of microencapsulated iron(I) sulfate; studies in mice. Bocci°, J. R., ZUBILLAGA, M. B., CARO, R. A., LYSIONEK, A., GOTELLI, C. A., GoTELLI, M. J., and WEILL, R. Biol. Trace Elem. Res., 1998, 62 (1 and 2), 65–73.
  • Biodistribution and tumor localization of stealth liposom al tumor necrosis factor-alpha in soft tissue sarcoma bearing rats. VAN DER VEEN, A. H., EGGERMONT, A. M., SEYNHAEVE, A. L., VAN TIEL, B., and TEN HAGEN, T. L. Int. J. Cancer, 1998, 77 (6), 901–906.
  • Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes. KANAMARU, T., TAKAGI, T., TAKAKURA, Y., and HASHIDA, M. J. Drug Targeting, 1998, 5 (4), 235–245.
  • Biologically active cam ptothecin derivatives for incorporation into liposome bilayers and lipid emulsions. LUNDBERG, B. B. Anticancer Drug Des., 1998, 13 (5), 453–461.
  • Biosimulation by liposome. AKIYOSHI, K. Kagaku to Kogyo ( Tokyo), 1998,51 (7), 1053–1056.
  • Bovine serum albumin loaded poly(lactide-co-glycolide) microspheres: the influence of polymer purity on particle characteristics. BITTNER, B., RONNEBERGER, B., ZANGE, R., VOLLAND, C., ANDERSON, J. M., and KISSEL, T. J. Microencapsulation, 1998, 15 (4), 495–514.
  • Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. STAHL, W., JUNGHANS, A., DE BOER, B., DRIOMINA, E. S., BinviriA, K., and SIES, H. FEBS Lett., 1998, 427 (2), 305–308.
  • Cationic liposome-mediated gene transfer. WANG, D., and Lm, Q. Shengwu Huaxue Yu Shengwu Wuli Jinzhan, 1997, 24 (6), 486–490.
  • Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. MEYER, 0., KIRPOTIN, D., HONG, K., STERNBERG, B., PARK, J. W., WOODLE, M. C., and PAPAHADJOPOULOS, D. J. Biol. Chem., 1998, 273 (25), 15621–15627.
  • Cationic multilamellar liposome-mediated human interferon-beta gene transfer into cervi-cal cancer cell. TOMODA, K., OHISHI, N., KIKKAWA, F., MIZUTANI, s., TOMODA, Y., and YAGI, K. Anticancer Res., 1998, 18 (3A), 1367–1371.
  • Cavity QED with whispering gallery modes of fused silica microspheres. VERNOOY, D. W., and KIMBLE, H. J. Proc. S PIE-Int. Soc. Opt. Eng., 1998, 3267 (Laser Resonators), 244–250.
  • Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method. LEO, E., PECQUETS, S., ROJAS, J., COUVREUR, P., and FATTAL, E.Microencapsulation, 1998, 15 (4), 421–430.
  • Characterization and measurement of microcapsule perm eability. XIE, Y., MA, X., Yu, X., and YUAN, Q. Mo Kexue Yu Jishu, 1997, 17 (2), 15–19.
  • Characterization of EDRF response by using liposome YYTIO in vitro and in vivo: implication of n itrosothiol formation to EDRF response. TAYAMA, S., AKAIKE, T., TSUNODA, R., Li, C. G., YOSHIDA, M., YASUE, H., and MAEDA, H. Portland Press Proc., 1998, 15 (Biology of Nitric Oxide, Part 6), 311.
  • Clonazepam microencapsulation in poly(m-lactide-co-glycolide) microspheres. BENELLI, P., CONTI, B., GENTA, I., COSTANTINI, M., and MONTANARI, L. J. Microencapsulation, 1998, 15 (4), 431–443.
  • Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel. CABANES, A., BRIGGS, K. E., GOKHALE, P. C., TREAT, J. A., and RAHMAN, A. Int. J. OncoL, 1998, 12 (5), 1035–1040.
  • Comparative study of the protection of modified and unmodified dsDNA by cationic and non-cationic lipids and liposom es to digestion by DNase I. LEGIDO, M., and ABELL, C. J. Chem. Soc., Perkin Trans., 1998, 2 (6), 1283–1286.
  • Comparison of a polymerized liposome with nonpolymerizable ones. CHUNG, Y. C., JEONG, J. M., and HWANG, J. H. Bull. Korean Chem. Soc., 1998, 19 (7), 780–784.
  • Comparison of different hydrophobic anchors conjugated to poly (ethylene glycol): effects on the ph arm ac okinetic s of liposom al vincristine. WEBB, M. S., SAXON, D., WONG, F. M., Lim, H. J., WANG, Z., BALLY, M. B., Clam, L. S., Cuws, P. R., and MAyER, L. D. Biochim. Biophys. Acta, 1998, 1372 (2), 272–82.
  • Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four am photericin B formulations. JooNsoN, E. M., OJWANG, J. 0., SZEKELY, A., WALLACE, T. L., and WARNocx, D. W. Antimicrob. Agents Chemother., 1998, 42 (6), 1412–1416.
  • Comparison of the immunological and protective responses elicited by microencapsulated formulations of the Fl antigen from Yersinia pestis. REDDIN, K. M., EASTERBROOK, T. J., ELEY, S. M., RUSSELL, p., MOBSBY, V. A., JoixEs, D. H., FARRAR, G. H., WILLIAMSON, E. D., and ROBINSON, A. Vaccine, 1998, 16 (8), 761–767.
  • Contribution of tryptophan residues to the structural changes in perfringolysin 0 during interaction with liposom al membranes. NAKAMURA, M., SEKINO, S. N., MITSUI, K., and OoNo, I. Y. J. Biochem. ( Tokyo), 1998, 123 (6), 1145–1155.
  • Controlled topical delivery of cyclosporin A from nonionic liposom al formulations: mechan-istic aspects. WARANUCH, N., RAMACHANDRAN, C., and WEINER, N. D. J. Liposome Res., 1998, 8 (2), 225–238.
  • Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma. BENNETT, C. L., GOLUB, R. M., STINSON, T. J., ABOULAFIA, D. M., VON ROENN, J., BOGNER, J., GOEBEL, F. D., and STEWART, S. J. Acquir. Immune. DOc. Syndr. Hum. Retrovirol., 1998, 18 (5), 460–465.
  • Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system. CROXFORD, J. L., TRIANTAPHYLLOPOULOS, K., PODHAJCER, 0. L., FELDMANN, M., BAKER, D., and CHERNAJOVSKY, Y. J. Immunol., 1998, 160 (10), 5181–5187.
  • Degradable starch microspheres (Spherex) significantly improve hyperthermic effects in laser-induced therm otherapy in a rat liver metastases model. ALBRECHT, D., GERMER, C. T., PELZ, J., ISBERT, C., RITZ, J. P., SCHUPPAN, D., and Bum, H. J. Chir. Forum Exp. Klin. Forsch., 1998, 607–609.
  • Delivery of an anti-HIV-1 ribozyme into HIV-infected cells via cationic liposom es. KONOPKA, K., Rossi, J. J., SWIDERSKI, P., SLEPUSHIGN, V. A., and DUZGUNES, N. Biochim. Biophys. Acta, 1998, 1372 (1), 55–68.
  • Design of microencapsulated chitosan microspheres for colonic drug delivery. LORENZO, L. M. L., REMUNAN, L. C., VILA, J. J. L., and ALoNso, M. J. J. Controlled Release, 1998, 52 (1-2), 109–118.
  • Determination of mitomycin in microcapsules by HPLC method. GENG, Y., MA, S., and CHEN, X. Zhongguo Kangshengsu Zazhi, 1998, 23 (1), 19–20.
  • Development of a new immunosensor for pesticide detection: a disposable system with liposome-enhancement and am perometric detection. BAUMNER, A. J., and SCHMID, R. D. Biosens. Bioelectron., 1998, 13 (5), 519–529.
  • Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides. Characterization of P(LA-GA)copolymer microspheres in vitro. LEWIS, K. J., IRWIN, W. J., and AKHTAR, S. J. Drug Targeting, 1998, 5 (4), 291–302.
  • Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer micro-spheres. GuprA, R. K., GRIFFIN, P. JR., RIATERA, R., and SIBER, G. R. Dev. Biol. Stand., 1998,92 (Modulation of the Immune Response to Vaccine Antigens), 277–287.
  • Development of flow-injection liposome immunoanalysis (FILIA) for imazethapyr. LEE, M., DURST, R. A., and WoNG, R. B. Talanta, 1998, 46 (5), 851–859.
  • Development of stable formulations for PLGA/PLA microsphere vaccines. CLELAND, J. L. Res. Immunol., 1998, 149 (1), 45–47.
  • Differences in the lipoprotein distribution of free, and liposome-associated all-trans-retinoic acid in human, dog,, and rat plasma are due to variations in lipoprotein lipid and protein content. WASAN, K. M., RAMASWAMY, M., NG, S. P., WONG, W., PARROTT, S. C., OJWANG, J. 0., WALLACE, T., and Cossum, P. A. Antimicrob. Agents Chemother., 1998, 42 (7), 1646–1653.
  • Different molecular weight chitosan microspheres: influence on drug loading and drug release. GENTA, I., PERUMNI, P., and PAVANETTO, F. Drug Dev. Ind. Pharm., 1998, 24 (8), 779–784.
  • Diffusion characteristics in microcapsules. YAO, S., and CHo, M. G. Chin. J. Chem. Eng., 1998,6 (2), 116–123.
  • Direct estimation of interaction potential between ph ospholipid liposome particle and glass surface by evanescent wave light scattering microscope method. TANIMOTO, S., TAKAHA-SHI, K., MATSUOKA, H., and YAMAOKA, H. Colloids Surf, A, 1998, 139 (3), 321–328.
  • Direct intracerebral delivery of carboplatin from PLGA microspheres against experimental malignant gliom a in rats. CHEN, W., HE, J., OLSON, J. J., and Lu, D. R. Drug Delivery, 1998,5 (2), 101–110.
  • Displacement of platelets from blood to spleen following intravenous injection of liposom es encapsulating dichlorom ethylene bisphosphon ate. SHIBAZAKI, M., NAKAMURA, M., NITTA, Y., and ENDO, Y. Immunopharmacology, 1998, 39 (1), 1–7.
  • E-SPART analysis of poly(D,L-lactide-co-glycolide) microspheres formulated for dry powder aerosols. PHILIP, V. A., MEHTA, R. C., DELUCA, P. P., and MAZUMDER, M. K. Part. Sci. Technol., 1998, 15 (3-4), 303–316.
  • Effect of current on dermal permeation of positively charged liposom es. LAD, M. R., MISRA, A. N., and PATEL, V. B. Indian J. Exp. Biol., 1998, 36 (6), 578–582.
  • Effect of dose and release rate on pulmonary targeting of liposom al triamcinolone acetonide phosphate. SUAREZ, S., GONZALEZ-ROTHI, R. J., SCHREIER, H., and HOCHHAUS, G. Pharm. Res., 1998, 15 (3), 461–465.
  • Effect of emulsifier blend on the characteristics of sustained release diclofenac micro-spheres. LEWIS, L., BoNI, R., and ADEYEYE, C. M. J. MicroencapsuL, 1998, 15 (3), 283–298.
  • Effect of liposome-encapsulated lc& or 13-interferon on breast cancer cell lines. CORADINI, D., PELLIZZARO, C., BIFFI, A., LOMBARDI, L., PIRRONELLO, E., RIVA, L., and Di FRONZO, G. Anticancer Res., 1998, 18 (1A), 177–182.
  • Effect of liposome-encapsulated hemoglobin on the development of endotoxin-induced shock in the rat. WHITEFORD, M., SPIRIG, A., RUDOLPH, A., NEVILLE, L., ABDULLAH, F., FEUERSTEIN, G., and RAMNOVICI, R. Shock, 1998, 9 (6), 428–433.
  • Effect of macrophage depletion by liposomes containing dichloromethylene-diphosphonate on endotoxin-induced uveitis. POUVREAU, I., ZECH, J. C., THILLAYE, G. B., NAUD, M. C., VAN ROOIJEN, N., and DE KOZAK, Y. J. NeuroimmunoL, 1998, 86 (2), 171–181.
  • Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique. Dm, L. Y and WAN, L. S. J. MicroencapsuL, 1998, 15 (3), 319–333. Effect of storage on the stability of DL-PLA microspheres containing methadone. DELGADO, A., EvouA, C., and LLABRES, M. Int. J. Pharm., 1998, 166 (2), 223–225.
  • Effect of ultrasound on the release of microencapsulated drugs. FRENKING, P. J. A., BOUAKAZ, A., DE JoNG, N., CATE, F. J. T., and KEATING, S. Ultrasonics, 1998, 36 (1-5), 709–712.
  • Effect on colon cancer cells of human interferon-13 gene entrapped in cationic multilamellar liposom es. SHIMIZU, M., AKIYAMA, S., Fro, K., KASAI, Y., TAKAGI, H., KITO, M., OHISHI, N., and YAGI, K. Biochem. MoL Biol. Int., 1998, 44 (6), 1235–1243.
  • Effective treatment of early endobronchial cancer with regional administration of liposom e-p53 complexes. Zou, Y ZONG, G., LING, Y. H., HAo, M. M., LozANo, G., HONG, W. K., and Pnunz-SoLnu, R. J. Natl. Cancer Inst., 1998, 90 (15), 1130–1137.
  • Effects of poly(vinylpyrrolidone) and ethyl cellulose on alginate microspheres prepared by emulsification. CHAN, L. W., and HENG, P. W. S. J. Microencapsulation, 1998, 15 (4), 409–420.
  • Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (stealth) liposomes: a randomized, double-blind clinical trial using a canine model. VAIL, D. M., CHUN, R., THAMM, D. H., GARRETT, L. D., COOLEY, A. J., and OBRADOVICH, J. E. Clin. Cancer Res., 1998, 4 (6), 1567–1571.
  • Embryo- and genotoxic effects of two endosulfan forms (powder and microcapsular) in cultures of mouse and rat pre- and postim plan tation embryos. POPOV, V. B., PROTASOVA, G. A., and RADILOV, A. S. Russ. J. Dev. Biol., 1998, 29 (2), 76–82.
  • Emulsification of liposomes with incomplete Freund's adjuvant: stability of the liposomes and the emulsion. MUDERHWA, J. M., ROTHWELL, S. W., and ALVING, C. R. J. Liposome Res., 1998, 8 (2), 183–194.
  • Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein. ABE, A., MIYANonARA, A., and FRIEDMANN, T. J. ViroL, 1998, 72 (7), 6159–6163.
  • Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents. AUDRAN, R., MEN, Y., JOHANSEN, P., GANDER, B., and CORRADIN, G. Pharm. Res., 1998,15 (7), 1111–1116.
  • Enhancement of liposom al adjuvant actions for tumor vaccines by increasing the degree of positive surface charge. NAKANISHI, T., KUNISAWA, J., HAYASHI, A., TSUTSUMI, Y., HAYAKAWA, T., and MAYUMI, T. Drug Delivery Syst., 1998, 13 (3), 151–157.
  • Entrapment of praziquantel in liposomes modifies effects of drug on morphology and motility of Me soce stoide s corti (syn. M. vogae, Ce stod a) tetrath yrid ia in mice. HRCKOVA, G., VELEBNY, S., and DEZFULI, B. S. Helminthologia, 1998, 35 (1), 13–20.
  • ESR study of the liposome membrane physical parameters in the heating-cooling cycles. PODOLAK, M., MAN, D., and PRZESTALSKI, S. Z-Naturforsch (C), 1998, 53 (3-4), 191–196.
  • Experim en tal and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer. SUGIYAMA, T., KUMAGAI, S., NISHIDA, T., USHIJIMA, K., MATSU°, T., YAKUSHIJI, M., HYON, S. H., and IKADA, Y. Anticancer Res., 1998, 18 (4B), 2837–2842.
  • Experimental study on administration of microencapsulated vibrio cholera vaccine. JiA, W., ZHANG, W., Li, X., DENG, X., XIONG, C., MENG, L., YANG, Y., XUN, X., and ZHENG, Z. Zhonghua Weishengwuxue He Mianyixue Zazhi, 1997, 17 (5), 342–347.
  • Fluorescent microspheres are superior to radioactive microspheres in chronic blood flow measurements. VAN OOSTERHOUT, M. F., PRINZEN, F. W., SAKURADA, S., GLENNY, R. W., and HALES, J. R. Am. J. PhysioL, 1998, 275 (1 Pt 2), H110–H115.
  • Formation of giant liposomes promoted by divalent cations: critical role of electrostatic repulsion. AKASHI, K. I., MIYATA, H., holt, H., and KINOSITA, K. JR. Biop hys. I, 1998,74 (6),2973–2982.
  • Formation of supramolecular structures by negatively charged liposomes in the presence of nucleic acids and divalent cations. MOZAFARI, M. R., ZAREIE, M. H., PISKIN, E.5 and HASIRCI, V. Drug Delivery, 1998, 5 (2), 135–141.
  • Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intra-venous administration. SONG, Y. K., and Liu, D. Biochim. Biophys. Acta, 1998, 1372(1), 141–150.
  • Function and structure of vein grafts following liposomal transfection with type III nitric oxide synthase. MILLER, V. M., SEVERSON, S. R., YAP, J. Y. M., and MCGREGOR, C. G. A. Portland Press Proc., 1998, 15 (Biology of Nitric Oxide, Part 6), 47.
  • Functionality of protective colloids affecting the formation, size uniformity and morphology of drug-free polylactic acid microspheres. LIN, S. Y., CHEN, K. S., and TENG, H. H. J. Microencapsul., 1998, 15 (3), 383–390.
  • Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. SIMOES, S., SLEPUSHKIN, V., GASPAR, R., PEDROSO DE LIMA, M. C., and DUZGUNES, N. Gene Ther., 1998, 5 (7), 955–964.
  • Gene transfer by HVJ (hem agglutinating virus of Japan)-liposome. KANEDA, Y. Kagalcu to Seibutsu, 1998, 36 (6), 376–384.
  • Generation of coated intermediates of clathrin-mediated endocytosis on protein-free lipo-some S. TAKEI, K., HAUCKE, V., SLEPNEV, V., FARSAD, K., SALAZAR, M., CHEN, H., and DE CAMILLI, P. Cell, 1998, 94 (1), 131–141.
  • HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using (3H)PK11195 as a marker for gliosis. CAMPION', E. G., NOBREGA, J. N., and SEFTON, M. V. Biomaterials, 1998, 19 (7-9), 829–837.
  • High resolution Mill of MCF7 human breast tumors: complemented use of iron oxide microspheres and Gd-DTPA. FURMAN, H. E., MARGALIT, R., GROBGELD, D., and DEGANI, H. .1. Magn. Reson. Imaging, 1998,8 (3), 634–641.
  • Human serum albumin microspheres approximate initial organ-specific biodistributions of transplanted hepatocytes and are effective cell surrogates for safety studies. RAJVANSHI, P., BHARGAVA, K. K., AFRIYIE, M., CAMAYA, M. V., GAGANDEEP, S., VASA, S. R., PALESTRO, C. J., and GuvrA, S. Cell Transplant, 1998, 7 (3), 275–283.
  • HVJ (Sendai virus) liposome-m ediated gene transfer: current status and future perspectives (review). YONEMITSU, Y., ALTON, E. W. F. W., KOMORI, K., YOSHIZUMI, T., SUGIMACHI, K., and KANEDA, Y. Int. J. Oncol., 1998, 12 (6), 1277–1285.
  • Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: Human serum proteins in vitro and rat proteins following implantation. BABENSEE, J. E., CORNELIUS, R. M., BRASH, J. L., and SEFTON, M. V. Biomaterials, 1998, 19 (7-9), 839–849.
  • In-vitro and in-vivo evaluation of commercial and microencapsulated sustained-release tablets containing diclofenac sodium. HOSNY, E. A., At-HEtw, A. A. R. M., and NIAZY, E. M. Saudi Pharm. J., 1998, 6 (1), 65–70.
  • In vitro and in vivo evaluation of insulin-producing 13TC6-F7 cells in microcapsules. Zuou, D., SUN, A. M., Li, X., MAMUJEE, S. N., VACEK, I., GEORGIOU, J., and WHEELER, M. B. Am. J. Physiol., 1998, 274 (5 Pt 1), C1356—C1362.
  • In-vivo evaluation of sustained-release microspheres of 5-FU in rabbits. ZINUTTI, C., BARBER', H. M., HOFFMAN, M., and MAINCENTT, P. Int. J. Phann., 1998, 166 (2), 231–234.
  • Induction of early and bioeffective antibody response in rodents with the luteinizing hormone-releasing hormone vaccine given as a single dose in biodegradable micro-spheres along with alum. DIWAN, M., DAWAR, H., and TALWAR, G. P. Prostate (N IT), 1998, 35 (4), 279–284.
  • Induction of protection against oral infection with cytotoxin-producing Escherichia coli 0157:H7 in mice by shiga-like toxin-liposome conjugate. FUKUDA, T., KIMIYA, T., TAKAHASHI, M., ARAKAWA, Y., Ami, y., SUZAKI, Y., NAITO, S., HORINO, A., NAGATA, N., SATOH, S., GONDAIRA, F., SUGIYAMA, J., NAKANO, Y., Mom, M., NISHINTOHARA, S., KOMURO, K., and UCHIDA, T. Int. Arch. Allergy Immtatol., 1998, 116 (4), 313–317.
  • Induction of protection against tetanus toxin in mice by tetanus toxoid-liposome conjugate. NAITO, S., HORINTO, A., KOMIYA, T., FUKUDA, T., TAKAHASHI, M., AMI, Y., SUZAKI, Y., OKA, T., OKUMA, K., MOROKUMA, M., NAKANO, Y., Mom, M., NISHINTOHARA, S., KOMURO, K., and UCHIDA, T. Int. Arch. Allergy Immunol., 1998, 116 (3), 215–219.
  • Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique. UGWOKE, M. I., and KINIGET, R. J. Microencapsul., 1998, 15 (3), 273–281.
  • Influence of shaking and surfactants on the release of BSA from PLGA microspheres. HERNADEZ, R. M., IGARTUA, M., GASCON, A. R., CALVO, M. B., and PEDRAZ, J. L. Eur. J. Drug Metab. Pharmacokinet., 1998, 23 (2), 92–96.
  • Influence of some lysosomotropic compounds on calcium ion desorption process from liposome membrane. KUCZERA, J., WITEK, S., KRAL, T. E., HLADYSZOWSKI, J., LUCZYNSKI, J., and PRZESTALSKI, S. Z Naturforsch (C), 1998, 53 (5-6), 389–397.
  • Inhibition of influenza virus replication by phosphorothioate and liposom ally end ocapsulated oligonucleofide S. ABE, T., HATTA, T., TAKAI, K., NAKASHIMA, H., YOKOTA, T., and TAKAKU, H. Nucleosides Nucleotides, 1998, 17 (1-3), 471–478.
  • Inhibition of tracheal vascular extravasation by liposome-encapsulated albuterol in rats. ZHANG, W., Guo, L., NADEL, J. A., and PAPAHADJOPOULOS, D. Pharm. Res., 1998, 15 (3), 455–460.
  • Interaction of ionic compounds with multilamellar liposomes. An electrokinetic model. MOLINA, F., LLACER, C., VILA, A. 0., PUCHOL, A., and FIGUERUELO, J. Colloids Surf, A, 1998, 140 (1–3), 91–101.
  • Interaction of the glycoprotein excreted by Pseudoalteromonas antarctica NE3 with phos-phafidylcholine liposomes. DE LA MAZA, A., PARRA, J. L., CONGREGADO, F., BOZAL, N., and GUINEA, J. Colloids Surf A, 1998, 137 (1-3), 181–188.
  • Investigation of new lipid microsphere-encapsulated antifungal drug. KINOSHITA, H. Wakayama Igaku, 1998, 49 (2), 153–165.
  • Investigation of production conditions of Th02-UO3 microspheres via the sol-gel process for pellet type fuels. TEL, H., ERAL, M., and ALTAS, Y. J. NucL Mater., 1998, 256 (1), 18–24.
  • Irradiation behavior of microspheres of U-Zr alloys. OGAWA, T., OGATA, T., box, A., AKABORI, M., MIYANISHI, H., SEKINO, H., NISHI, M., and IsnixAwA, A. J. Alloys Compd., 1998, 271–273. 670–675.
  • Is liposom al am photericin B (Am bisom e) an effective prophylaxis of mycotic infections after liver transplantation? BRAUN, F., RUCHEL, R., LORF, T., CANELO, R., MULLER, A., SATTLER, B., and RINGE, B. Transplant Proc., 1998, 30 (4), 1481–1483.
  • Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated prom astigote antigens. AFRIN, F., and ALI, N. J. Parasitol., 1998, 84 (4), 743–748.
  • Lectin recognition of liposomes containing neoglycolipids. Influence of their lipidic anchor and spacer length. GELHAUSEN, M., BESSON, F., CHIERICI, S., LAFoNT, D., BOULLANGER, P., and Roux, B. Colloids Surf, B, 1998, 10 (6), 395–404.
  • Liposom al delivery of oOnterferon to m urine bladder tumor cells via transferrin receptor-mediated endocytosis. Lmo, W. P., DEHAVEN, J., SHAO, J., CHEN, J. X., ROJANASAKUL, Y., LAmm, D. L., MA, J. K. H. Drug Delivery, 1998,5 (2), 111–118.
  • Liposom al formulations of synthetic MUCI peptides: effects of encapsulation versus surface display of peptides on immune responses. GUAN, H. H., BUDZYNSKI, W., KOGANTY, R. R., KRANrz, M. J., REDDISH, M. A., ROGERS, J. A., LONGENECKER, B. 1\4.5 and SAMUEL, J. Bioconjugate Chem., 1998, 9 (4), 451–458.
  • Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo. IKEzAKI, H., ONYUKSEL, H., and RUBINSTEIN, I. An J. Physiol., 1998, 275 (2 Pt 2), R588–R595.
  • Liposome-anchored vascular endothelial growth factor aptamers. WILLIS, M. C., COLLINS, B., ZHANG, T., GREEN, L. S., SEBESTA, D. P., BELL, C., KELLOGG, E., GILL, S. C., MAGALLANEZ, A., KNAUER, S., BENDELE, R. A., GILL, P. S., and JANjic, N. Bioconjugate Chem., 1998, 9 (5), 573–582.
  • Liposome and its application. Zilou, L., and Wu, X. Xiandai Huagong, 1997, 17 (9), 18–20.
  • Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE): a ran-domized clinical trial in dogs with mammary carcinoma. TESKE, E., RUTTEMAN, G. R., V-D-INGH, T. S. G. A. M., VAN NOORT, R., and MISDORP, W. Anticancer Res., 1998, 18 (2A), 1015–1019.
  • Liposome encapsulated vitamin A compounds exhibit greater stability and diminished toxicity. SINGH, A. K., and DAS, J. Biophys. Chem., 1998, 73 (1-2), 155–162.
  • Liposome encapsulation of cytostatic and degradable starch microspheres improve tumor targeting in hepatic arterial infusion therapy (HAI). An experimental study on the CC531 tum or in rat liver. BERGER, G., RESZKA, R., POHLEN, U., JUNG, M., LUCAS, S., and BUHR, H. J. Chir. Forum Exp. Klin. Forsch., 1998, 693–697.
  • Liposome immunoassay by long-lived fluorescence detection. OKABAYASHI, Y., and IKEucHL I. Analyst ( Cambridge, UK), 1998, 123 (6), 1329–1332.
  • Liposome-induced conformational changes of an epitopic peptide and its palmitoylated derivative of influenza virus hem agglutinin. LACZKO, I., HoLLosi, M., VASS, E., and Tont, G. K. Biochem. Biophys. Res. COMMIT,. 1998, 249 (1), 213–217.
  • Liposome-mediated gene transfer into bone marrow cells and its in vitro expansion. Lu, H., Zou, P., LI, C., and Yu, D. Zhonghua Xueyexue Zazhi, 1997, 18 (8), 422–424.
  • Liposome mediated gene transfer into GH3 cells, and rat brain, liver and gut: comparison of different polar or aliphatic domains. KATSEL, P. L., O'CONNELL, B., MEZUMO, T., MOBBS, C. V., and GREENSTEIN, R. J. Nucleic Acids Symp. S er., 1998,38 (Advances in Gene Technology: Molecular Biology in the Conquest of Disease), 33–34..
  • Liposome: a suitable carrier for dermal topical administration. Zxu, Y. C., and LL H. Y. Zhongguo Yiyao Gongye Zazhi, 1998, 29 (5), 231–235.
  • Liposomes containing boronophenylalanine for boron neutron capture therapy. PERUGINI, P., and PAvANErro, F. J. Microencapsulation, 1998, 15 (4), 473–483.
  • Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS, S malaria antigen. RICHARDS, R. L., RAo, M., WASSEF, N. M., GLENN, G. M., ROTHWELL, S. W., and ALVING, C. R. Infect. 11111111111. 1998, 66 (6), 2859–2865.
  • Liposomes enriched in oleic acid are less susceptible to oxidation and have less proinflam-matory activity when exposed to oxidizing conditions. LEE, C., I3ARNETT, J., and REAVEN, P. D. J. Lipid Res., 1998,39 (6), 1239–1247.
  • Liposomes with metronidazole for topical use: the choice of preparation method and vehicle. SKALKO, N., CAJKOVAC, M., and JALSENJAK, I. J. Liposome Res., 1998, 8 (2), 283–293.
  • Liposomes: from membrane models to gene therapy. SCHUBER, F., KICHLER, A., BOECKLER, C., and FRISCH, B. Pure AppL Chem., 1998, 70 (1), 89–96.
  • Major limitations in the use of cationic liposomes for DNA delivery. FILION, M. C., and PHILLIPS, N. C. Int. J. Pharm., 1998, 162 (1-2), 159–170.
  • Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension. WEISS, G., KLEmm, F. H., FucHs, W. S., STANISLAUS, F., ZEmA, M., and CALANcm, M. Arzneimittelforschung, 1998, 48 (5A), 604–612.
  • Massage-induced release of subcutaneously injected liposome-encapsulated drugs to the blood. TRUBETSKOY, V. S., WHITEMAN, K. R., TORCHILIN, V. P., and WOLF, G. L. J. Controlled Release, 1998, 50 (1-3), 13–19.
  • Mechanical and fracture behavior of composite materials composed of a matrix of PMMA and glass microspheres. MASPOCH, M. L., VELASCO, J. I., GORDILLO, A., and MORHAIN, C. Inf. TecnoL, 1998, 9 (3), 223–228.
  • Membrane fluidity imaging of liposomes and cells by using environment-sensitive probes. OHBA, T. Maku, 1998, 23 (4), 196–203.
  • Microencapsulated fire retardants for flame-resistant tentage textiles. KOVAR, R. F., FARREL, B., TIAN°, T., LEVI, R., and HARPEL, J. W. H. Recent Adv. Flame Retard. Polym. Mater., 1997,8, 88–97.
  • Microencapsulated phase-change materials as heat transfer media in gas-fluidized beds. BROWN, R. C., RASBERRY, J. D., and OVERMANN, S. P. Powder Technol., 1998, 98 (3), 217–222.
  • Microencapsulation and control of the conductivity of polymer composites. HENRY, F., EPRON, F., DEGOBERT, p., FLAVIN, E., and MONTANT RAMANITRA, L. J. Chim. Phys. Phys. Chin. Biol., 1998, 95 (6), 1291–1294.
  • Microencapsulation by spray drying. RE, M. I. Drying TechnoL, 1998, 16 (6), 1195–1236. Microencapsulation of fine particles in a fluidized bed. NIEHAUS, M., and WEISWEILER, W. Int. Annu. Conf. ICT, 1998, 29 (Energetic Materials), 80.1–80.7.
  • Microencapsulation of the renin inhibitor FK906 by phase separation of ethylcellulose in cyclohexane. WEISS, G., YAMAGUCHI, H., IBuxi, R., YASUMURA, M., and OHNISHI, N. J. MicroencapsuL, 1998, 15 (3), 335–346.
  • Microencapsulation: the future of oral immunotherapy? LtrwiN, A., FLANAGAN, M., and MICHAEL, J. G. BioD rugs, 1998, 9 (4), 261–270.
  • Microsphere impact near surface capture conditions. DUNN, P., LI, X., and BRACH, R. 1998, Proc. Annu. Meet. Adhes. Soc., 21, 284–286.
  • Microstructure of microcapsules consisting of whey proteins and carbohydrates. SHEU, T. Y., and RosENTBERG, M. J. Food Sci., 1998, 63 (3), 491–494.
  • Modulation of the immune response to tetanus toxoid by polylactide-polyglcolide micro-spheres. WALKER, K. B., XING, D. K. L., SESARDIC, D., and CORBEL, M. J. Dev. Biol. Stand., 1998, 92 (Modulation of the Immune Response to Vaccine Antigens), 259–267.
  • Molecular characterization and liposom al transfection of a p53-mutated cell line established from a poorly differentiated leiom yosarcom a. MEYE, A., BACHE, M., HINTZE, R., SCHMIDT, H., Won., P., HOLZHAUSEN, H. J., RATH, F. W., and TAUBERT, H. Int. J. OncoL, 1998, 13 (2), 241–248.
  • Multidrug-resistant acute leukemia cells are responsive to prolonged exposure of daunor-ubicin: implications for liposome-encapsulated daunorubicin. VERDONCK, L. F., LOKHORST, H. M., ROOVERS, D. J., and VAN HEUGTEN, H. G. Leulc. Res., 1998, 22 (3), 249–256.
  • New pH-sensitive liposomes using bis(6-hemisuccinyloxyhexyl) fumarate. JiN, J. Y., and LEE, Y. S. Bull. Korean Chem. Soc., 1998, 19 (6), 645–649.
  • New strategies for the microencapsulation of tetanus vaccine. SCHWENDEMAN, S. p., TOBIO, M., JOWOROWICZ, M., ALONSO, M. J., and LANGER, R. J. Microencap.suL, 1998, 15 (3), 299–318.
  • Novel applications of liposom es. LASIC, D. D. Trends. BiotechnoL, 1998, 16(7), 307–321. 108 Refs.
  • Novel microdesign of oxidation catalysts. Part 1. Glass crystal microspheres as new catalysts for the oxidative conversion of methane. FOMENKO, E. V., KONDRATENKO, E. V., SALANOV, A. N., BAJuxov, 0. A., TALYSHEV, A. A., MAKSIMOV, N. G., Nizov, V. A., and ANSHITS, A. G. CataL Today, 1998, 42 (3), 267–272.
  • Novel microdesign of oxidation catalysts. Part 2. The influence of fluorination on the catalytic properties of glass crystal microspheres. FOMENKO, E. V., KONDRATENKO, E. V., SHARONOVA, 0. M., PLEKHANOV, V. P., KOSHCHEEV, S. V., BORONINT, A. I., SALANOV, A. N., BAJUKOV, 0. A., and ANSHITS, A. G. CataL Today, 1998, 42 (3), 273–277.
  • Optical microsphere resonators: optimal coupling and the ultimate Q. GORODETSKY, M. L., SAVCHENKOV, A. A., and BEHENKo, V. S. Proc. SPIEInt. Soc. Opt. Erzg., 1998, 3267 (LaserResonators), 251–262.
  • Optimization of the microencapsulated islet for transplantation. GARFINKEL, M. R., HARLAND, R. C., and OPARA, E. C. J. Surg. Res., 1998, 76 (1), 7–10.
  • Oral administration of liposomes containing cyclosporin: a pharmacokinetic study. AL-MESHAL, M. A., KHIDR, S. H., BAYOMI, M. A., and AL-ANGARY, A. A. Int. J. Pharm., 1998, 168 (2), 163–168.
  • Ordering structure of the microspheres in blend films. SAITO, R., TANAKA, S., and Ismzu, K. Polymer, 1998, 39 (13), 2917–2920.
  • Ovalbumin coupled either with murine red blood cells or liposome induces IgG but not IgE antibody production. UCHIDA, T., NAITO, S., HORINO, A., TANEICHI, M., MIZUGUCHI, J., NAKANO, Y., OKA, T., OOKUMA, K., MOROKUMA, K., SAKURAL, S., and KOMURO, K. Dev. Biol. Stand., 1998, 92 (Modulaticn of the Immune Response to Vaccine Antigens), 353–363.
  • Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcom a: results of a randomized phase III clinical trial. NORTHFELT, D. W., DEZUBE, B. J., THOMMES, J. A., MILLER, B. J., FISCHL, M. A., FRIEDMAN, K. A., KAPLAN, L. D., Du-Mom), C., MAMELOK, R. D., and HENRY, D. H. J. din. OncoL, 1998, 16 (7), 2445–2451.
  • pH and ion-triggered volume response of anionic hydrogel microspheres. EICHENBAUM, G. M., KISER, P. F., SIMON, S. A., and NEEDHAM, D. Macromolecules, 1998, 31 (15), 5084–5093.
  • pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in quasi-anhydrous samples. DE OLIVEIRA, M. C., FATTAL, E., COUVREUR, p., LESIEUR, p., BOURGAUX, C., OLLIVON, M., and DUBERNET, C. Biochim. Biophys. Acta, 1998, 1372 (2), 301–310.
  • Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet. FUCHS, W. S., WEISS, G., VON NIECIECKI, A., LAICHER, A., GAY, S., PABST, G., and MULLER, M. Arzneimittelforschung, 1998, 48 (5A), 612–617.
  • Pharmacokinetics, cell toxicity, antitumor activity and spleen/blood cell toxicity of aclar-ubicin-entrapped liposomes. PARK, M. S., PARK, J. K., LEE, G. W., MYUNG, P. K., SOK, D. E., HwANG, S. J., and JEE, U. K. Yakhak Hoechi, 1998, 42 (3), 275–283.
  • Photophysical properties of porphyrin planar aggregates in liposomes. RICCHELLI, F., GOBBO, S., MORENO, G., SALET, C., BRANCALEON, L., and MAZZINI, A.. Eur. J. Biochem., 1998, 253 (3), 760–765.
  • Physicochemical and morphological properties of complexes made of cationic liposomes and oligonucleofides. JAASKELAINEN, I., STERNBERG, B., MONKKONEN, J., and URTTI, A. Int. J. Pharm., 1998, 167 (1-2), 191–203.
  • Plasma lipoprotein distribution ofliposom al nystatin is influenced by protein content of high-density lipoproteins. CASSMY, S. M., STROBEL, F. W., and WASAN, K. M. Antimicrob. Agents Chemother., 1998, 42 (8), 1878–1888.
  • Polyacrolein-containing microspheres: synthesis, properties and possible medical applica-tions. SLOMKOWSKI, S. Prog. Polym. Sci., 1998, 23 (5), 815–874.
  • Polyamide microcapsules containing alginic acid: extractability of metal ions and surface characterization by XPS. ASAKI, M., ICHINOSE, T., MONJUSHIROH, H., FUKUMOTO, T., and WATARAI, H. J. Microencapsulation, 1998, 15 (4), 453–463.
  • Possibility of cytomedical therapy for diabetes mellitus using microencapsulated pancreatic 13 cell line with glucose sensor. YOSHIOKA, T., OKADA, N., MIYAMOTO, H., SAKAMOTO, K., TSUTSUMI, Y., NAKAGAWA, S., MIYAZAKI, J., and MAYUMI, T. Drug Delivery Syst, 1998,13 (2), 95–100.
  • Preparation and characterization of am picillin loaded methylpyrrolidinone chitosan and chitosan microspheres. GIUNCHEDI, P., GEN-1'A, I., CoNti, B., MUZZARELLI, R. A. A., and CoNTE, U. Biomaterials, 1998, 19 (1-3), 157–161.
  • Preparation and characterization of differently charged lysozyme liposomes. YANG, W. Thongguo Shenghua Yaowu Zazhi, 1998, 19 (2), 58–62.
  • Preparation and characterization of pH-sensitive proteinoid microspheres for the oral delivery of methotrexate. KUMAR, A. B. M., and RAo, K. P. Biomaterials, 1998, 19 (7-9), 725–732.
  • Preparation and drug-delivery characterization of netted liposomes. ZHANG, J., DE, Z., FAN, C., ZHEN, P., and Zum, R. Wuhan Daxue Xuebao, Ziran Kexueban, 1997, 43 (4), 453–457. Preparation and evaluation of aclarubicin liposome using microfluidizer. PARK, M. S., PARK, J. K., LEE, G. W., BAEK, M. K., and JEE, U. K. Yakhak Hoechi, 1998, 42 (3), 265–274.
  • Preparation and evaluation of in vitro dissolution characteristics of sustained release metoprolol tartrate microcapsules. EL-SAYED, M. M. Zagazig J. Pharm. Sci., 1997, 6 (1), 99–104.
  • Preparation and evaluation of sustained release cross-linked chitosan microspheres contain-ing phenobarbitone. AL-HELw, A. A., AL-ANGARY, A. A., MAHROUS, G. M., and AL-DARDARI, M. M. J. MicroencapsuL, 1998, 15 (3), 373–382.
  • Preparation and in vitro characterization of Eudragit RL 100 microspheres containing 5-fluorouracil. PARIKH, J. R., MURTHY, R. S. R., and PARIKH, R. H. Indian J. Pharm. Sci., 1998, 60 (2), 107–109.
  • Preparation of colored microspheres by dispersion polymerization. SAITO, N., TAGUCHI, Y., and TANAKA, M. Shikizai Kyokaishi, 1998, 71 (4), 232–238.
  • Preparation of liposome-encapsulating adenosine triphosphate. ARAKAWA, A., IsinGuRo, S., Onxi, K., and TAMAI, M. Tohoku. J. Exp. Med., 1998, 184 (1), 39–47.
  • Preparation of monodisperse and big diameter polystyrene microspheres. KANG, J., and WEI, S. Beijing Yike Daxue Xuebao, 1997, 29 (3), 238–240.
  • Preparation of monodisperse poly(acrylamide-co-acrylic acid) hydrogel microspheres by a membrane emulsification technique and their size-dependent surface properties. NAGASHIMA, S., ANDO, S., TSUKAMOTO, T., OHSHIMA, H., and MAKIN°, K. Colloids Surf, B, 1998, 11 (1/2), 47–56.
  • Preparation of poly (m.-lactide-co-glycolide)microspheres containing testosterone and drug release in vitro. Zuu, J., SHEN, Z., WANG, F., and MA, Z. Zhongguo Yaoxue Zazhi (Beijing), 1997, 32 (10), 595–598.
  • Preparation of poly(lactic acid) m icrocapsules containing ciprofloxacin. Yu, W. P., WONG, J. P., and CHANG, T. M. S. J. Microencapsulation, 1998, 15 (4), 515–523.
  • Preparation of two dosage forms containing antitumor prostaglandin, and their antitumor effect in vitro and in vivo: lipiodol solution for I.A. administration and lipid micro-spheres for I.P. or I.V. administration. Snop, F., MASAHIRO, N., Yosnn(Azu, T., and MAsANom, F. Adv. Exp. Med. Biol., 1997, 400B (Eicosanoids and Other Bioactiye Lipids in Cancer, Inflammation, and Radiation Injury 2, Pt. B), 955–961.
  • Preparation, characterization and application of magnetic microsphere. ZHANG, J., JIANG, Z., WANG, R., CHEN, H., LIAO, S., and SHEN, D. Huaxue Tongbao, 1997, (9), 55–57.
  • Production and antiproliferative activity of liposomes containing the antitumor drug chro-m om ycin A3. CORTESI, R., ESPOSITO, E., MAIETTI, A., MENEGATTI, E., and NASTRUZZI, C. J. Microencapsulation, 1998, 15 (4), 465–472.
  • Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. JAMEELA, S. R., KUMARY, T. V., LAL, A. V., and JAYAKRISHNAN, A. J. Controlled Release, 1998, 52 (1-2), 17–24.
  • Prolonged systemic delivery of streptokinase using liposome. KIM, I. S., Cnoi, H. G., Cnoi, H. S., KIM, B. K., and KIM, C. K. Arch. PharmacaL Res., 1998, 21 (3), 248–252.
  • Pyrolysis of phenol-formaldehyde resin microspheres with phosphorus-containing additives at the surface. TRIFONOV, S. A., and MALYGIN, A. A. Plast Massy, 1997, (5), 37–39.
  • Raman spectroscopic study of microcosmic and photosensitive damage on the liposomes of the mixed phospholipids sensitized by hypocrellin and its derivatives. Xu, Y., ZHAO, H., and ZHANG, Z. J. Photochem. PhotobioL B, 1998, 43 (1), 41–46.
  • Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs. KONOPKA, K., DUZGUNES, N., Rossi, J., and LEE, N. S. J. Drug Targeting, 1998, 5 (4), 247–259.
  • Regional cerebral blood flow measurements by a noninvasive microsphere method using 123I-IM comparison with the modified fractional uptake method and the continuous arterial blood sampling method. NAKANO, S., MATSUDA, H., TANIZAKI, H., OGAWA, M., MIYAZAKI, Y., and YONEKURA, Y. Kaku Igaku, 1998, 35 (4), 209–218.
  • Regional lung deposition of nebulized liposome-encapsulated ciprofloxacin. FINLAY, W. H., and WoNG, J. P. Int. J. Pharm., 1998, 167 (1-2), 121–127.
  • Release and bioavailability of diclofenac sodium from low molecular weight chitosan microspheres treated with Japan and carnauba wax. AL-ANGARY, A. A., ABD-AL-RAHEEM, M. A. H., AL-DARDIRI, M. M., and MAHROUS, G. M. Pharm. Ind., 1998, 60 (7), 629–634.
  • Release of enzymes from liposomes during cheese ripening. LALOY, E., VUILLEMARD, J. C., DuFouu, P., and SIMARD, R. J. Controlled Release, 1998, 54 (2), 213–222.
  • Repeat injection studies of technetium-99m-labeled PEG-liposomes in the same animal. COINS, B., PHILLIPS, W. T., and KLIPPER, R. J. Liposome Res., 1998, 8 (2), 265–281.
  • Rhenium-188 microspheres: a new radiation synovectomy agent. WANG, S. J., LENT, W. Y., CHEN, M. N., HSIEH, B. T., SHEN, L. H., TSAI, Z. T., TING, G., CHEN, J. T., Ho, W. L., MIRZADEH, S., and KNAPP, F. F. JR. NucL Med. Commun., 1998, 19 (5), 427–433.
  • Role of liposomes in selective proliferation of splenic lymphocytes. SEHRA, S., CHuGH, L., and GANGAL, S. V. MoL Cell Biochem., 1998, 183 (1&2), 133–139.
  • Role of monensin PLGA polymer nanoparticles and liposomes as potentiator of ricin A immunotoxins in vitro. EERDOUS, A. J., STEMBRIDGE, N. Y., and SINGH, M. J. Controlled Release, 1998, 50 (1-3), 71–78.
  • Selective targeting of Kupffer cells with liposom al butyrate augments portal venous transfu-sion-induced immunosuppression. PEREZ, R. V., JOHNSON, J., HUBBARD, N. E., ERICKSON, K., MORGAN, M., KIM, S., RUDICH, S. M., KATZNELSON, S., and GERMAN, J. B. Transplantation, 1998, 65(10), 1294–1298.
  • Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasm id DNA-liposome complex. ImAoEA, T., DATE, I., OHMOTO, T., and NAGATSU, T. Hum. Gene Ther., 1998, 9 (7), 1093–1102.
  • Simultaneous determination of twelve benzodiazepines in human serum using a new reversed-phase chromatographic column on a 2-µm porous microspherical silica gel. TANAKA, E., TERADA, M., MISAWA, S., and WAKASUGI, C. J. Chromatogr., B: Biomed. Sci. AppL, 1998, 709 (2), 324.
  • Size characterization of liposomes by flow field-flow fractionation and photon correlation spectroscopy Effect of ionic strength and pH of carrier solutions. MOON, M. H., PARK, I., and KIM, Y. J. Chromatogr., A, 1998, 813 (1), 91–100.
  • Sorption of hydrophobic, negatively charged microspheres onto a stagnant air/water inter-face. ABDEL, F. A. I., and ELGENK, M. S. J. Colloid Interface Sci., 1998, 202 (2), 417–429.
  • Specific inhibition of influenza virus RNA polym erase and nucleoprotein gene expression by liposom ally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells. ABE, T., SUZUKI, S., HATTA, T., TAKAI, K., YOKOTA, T., and TAKAKU, H. Antiviral Chem. Chemother., 1998, 9 (3), 253–262.
  • Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electro-phoresis. IGARTUA, M., HERNANDEZ, R. M., ESQUISABEL, A., GASCON, A. R., CALVO, M. B., and PpopAz, J. L. Int. J. Pharm., 1998, 169 (1), 45–54.
  • Stabilization and regulated fusion of liposom es containing a cationic lipid using am phipathic polyethylene glycol derivatives. Mom, A., CHONN, A., Cnoi, L. S., ISRAELS, A., MONCK, M. A., and CuLLis, P. R. J. Liposome Res., 1998, 8 (2), 195–211.
  • Stabilization of dichloromethane-induced protein denaturation during microencapsulation. RAGHUVANSHI, R. S., GOYAL, S., SINGH, 0., and PANDA, A. K. Pharm. Dev. Technol., 1998,3 (2), 269–276.
  • Stimulation of hemopoiesis and protection of mice against radiation injury by synthetic analogs of muramyldipeptide incorporated in liposomes. TURANEK, J., ZALUSKA, D., HOFER, M., VACEK, A., LEDVIN, M., and JEZEK, J. Int. J. ImmunopharmacoL, 1998, 19 (9/10), 611–617.
  • Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposom al system. ARORA, A., NAIR, M. G., and STRASBURG, G. M. Free Radical. Biol. Med., 1998, 24 (9), 1355–1363.
  • Structure optimization of polylactide microcapsules for controlled drug release. PLAVSIC, M., TOMIC, S., SAJC, L., BUGARSKI, B., and JovANoinc, G. Mater. Sci. Forum, 1998, 282–283 (Advanced Materials and Processes), 271–280.
  • Studies on electroless cobalt coatings for microencapsulation of hydrogen storage alloys.
  • HARAN, B. S., Popov, B. N., and WHITE, R. E. J. Electrochem. Soc., 1998, 145 (9), 3000–3007. Study of azathioprine encapsulation into liposomes. GULATI, M., GROVER, M., SINGH, M., and
  • SINGH, S. J. Microencapsulation, 1998, 15 (4), 485–494.
  • Study on diffusion model of bio microcapsules. XIE, Y., MA, X., WANG, Y., and Yu, X. Mo Kexue Yu Jishu, 1997, 17 (4), 51–56.
  • Study on synthesis and properties of pressure-sensitive color-developing microcapsule. Effects of melamine resin concentration distribution and core-to-shell ratio on per-formance of manufactured microcapsules. Lu, J., QIAN, L., CHEN, S., and HUA, Z. Thongguo Fangzhi Daxue Xuebao, 1997, 23 (3), 37–42.
  • Study on thermal stability of phenol-formaldehyde resin solution and its microsphere prod-ucts. LI, Z., and WANG, G. Kuangye (Be(ing), 1998, 7 (1), 5–7.
  • Studying the effect of plasticizer on Eudragit RS100 microspheres prepared by solvent evaporation technique. MADY, 0. Y., MABROUK, M. M., and RIBITISCH, V. Bull. Fac. Pharm. (Cairo Univ. ), 1997, 35 (3), 251–256.
  • Subsolubilizing alterations caused by alkyl glucosides in phosphatidylcholine liposomes. DE-LA-MAzA, A., CODERCH, L., GONZALEZ, P., and PARRA, J. L. J. Controlled Release, 1998, 52 (1-4 159–168.
  • Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgi-cal debridement, and the use of systemic liposom al am photericin B and local therapy with nebulized am photericin—a case report. RAJ, P., VELLA, E. J., and BICKERTON, R. C. J. LaryngoL OtoL, 1998, 112 (4), 367–370.
  • Suppression of immunological response against a transgene product delivered from micro-encapsulated cells. POTTER, M. A., HYMUS, S., STOCKLEY, T., and CHANG, P. L. Hum. Gene Ther., 1998, 9 (9), 1275–1282.
  • Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJliposom es. SAEKI, Y., WATAYA, K. M., TANAKA, K., and KANEDA, Y. Gene Ther., 1998, 5 (8), 1031–1037.
  • Synthesis and characterization of polymeric microsphere with high adsorption rate. YANG, D., Wu, Z., UN, Y and Yu, K. Taiyuan Ligong Daxue Xuebao, 1998, 29 (3), 250–252. 255. Synthesis of crosslinked polymer microspheres in supercritical carbon dioxide. COOPER, A. I., HEMS, W. P., and HOLMES, A. B. Macromol. Rapid ConvntaL, 1998, 19 (7), 353–357.
  • Synthesis of microcapsule by Staphylococcus aureus is not responsive to environmental phosphate concentrations. Fox, K. F., STEWART, G. C., and Fox, A. Infect. Immun., 1998, 66 (8), 40011 11007.
  • Systemic gene therapy using liposomes. PARK, Y. S. S aenghwahak Nyusu, 1997, 17 (4), 191–195. The 58-kDa microspherule protein (M5P58), a nucleolar protein, interacts with nucleolar protein p120. REN, Y., Buscx, R. K., PERLAKY, L., and Buscx, H. Eur. J. Biochem., 1998, 253 (3), 734–742.
  • The inhibitory effects of water-soluble and liposomal I3-carotene in various models of carcinogenesis. ALEKSANDROV, V. A., BESPALOV, V. G., PETROV, A. S., and AVTUSHENKO, S. S. Vopr. Onkol., 1998, 44 (1), 79–85.
  • The interaction of phospholipase A2 with liposomes: an immunological approach to its study. MORALES, R., ZAVALA, E., and FERNANDEZ, M. S. Biochem. Mol. Biol. Int., 1998, 44 (6), 1111–1118.
  • The reactivities of concanavalin with membranes of ischemic myocardium injury and membranes protected by soybean phospholipid liposome in rats. ZHANG, Y., ZHou, X., WANG, X., FENG, X., Dm, J., and CHEN, X. Hubei Yike Daxue Xuebao, 1998, 19 (1), 16–17. 21.
  • The stabilizing effect of sulfoquinovosyl diacylglycerol on liposomes. HAN, X., and Li, G. Zliongguo Shengwu Huaxue Yu Fenzi Shengwu Xuebao, 1998, 14 (3), 342–345.
  • The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice. BEI, R., GrucTILL, V., MASUELLI, L., KASHMIR', S. V. S., MURARO, R., FRATI, L., SCHLOM, J., and KANTOR, J. J. Immtatother., 1998, 21 (3), 159–169.
  • Therapeutic effects of 5-fluorouracil microspheres on peritoneal carcinomatosis induced by Colon 26 or B-16 melanoma in mice. HAGIWARA, A., SAKAKURA, C., SHIRASU, M., YAMASAKI, J., TOGAWA, T., TAKAHASHI, T., MURANISHI, S., HYON, S., and IKADA, Y. Anticancer Drugs, 1998, 9 (3), 287–289.
  • Therapeutic uses of microencapsulated genetically engineered cells. CHANG, T. M., and PRAKAsu, S. MoL Med. Today, 1998, 4 (5), 221–227. 31 Refs.
  • Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using lipo-some-encapsulated im m unom odulators. KILLION, J. J., and FIDLER, I. J. Pharmacol. Ther., 1998, 78 (3), 141–154.
  • Thermo-sensitivity of polymeric liposomes. Liu, Z., CHEN, M., ZHANG, J., FAN, C., and Zuuo, R. Zliongguo Yaoxue Zazhi (Be(ing), 1997, 32 (10), 593–595.
  • Therm oresponsive release from poly(Glu(OMe))-block-poly(Sar) microcapsules with sur-face-grafting of poly(N-isopropylacrylamide). KIDCHOB, T., KIMURA, S., and IMANISHI, Y. J. Controlled Release, 1998, 50 (1-3), 205–214.
  • Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in m urine melanoma. SHARMA, D., CHELVI, T. P., KAUR, J., and RALHAN, R. Melanoma Res., 1998, 8 (3), 240–244.
  • TIRM measurements with cells and liposomes. ROBERTSON, S. K., UHRicE, A., and BIKE, S. G. J. Colloid Interface ScL, 1998, 202 (1), 208–211.
  • Toxicity of liposomal 31-5'-0-dipalmitoy1-5-fluoro-21-deoxyuridine in mice. VAN BORSSUM, W. M., GORIS, H., DONTJE, B. H. J., SCHWENDEVER, R. A., SCHERPHOF, G., and NijuoF, W. Anti Cancer Drug Des., 1998, 13 (4), 291–305.
  • Transfer of second messengers through gap junction connexin 43 channels reconstituted in liposomes. KAm, Y., Kim, D. Y., Koo, S. K., and JoE, C. 0. Biochim. Biophys. Acta, 1998,1372 (2), 384–388.
  • Trehalose increases freeze-thaw damage in liposom es containing chloroplast glycolipids. IlmrcHA, D. K., and CROWE, J. H. Cryobiology, 1998, 36 (3), 245–249.
  • Triggerable liposomal fusion by enzyme cleavage of a novel peptide-lipid conjugate. PAK, C. C., ALI, S., JANOFF, A. S., and MEERS, P. Biochim. Biophys. Acta, 1998, 1372 (1), 13–27.
  • Tumor regression under long-term application of liposome-encapsulated 5-FU. POHLEN, U., BERGER, G., JUNG, M., REZSKA, R., REGENSTEIN, J., and BUHR, H. J. Chir. Forum Exp. Klin. Forsch., 1998, 625–629.
  • Vasodilation elicited by liposom al VIP is unimpeded by anti-VIP antibody in hamster cheek pouch. IKEZAKI, H., PAUL, S., ALKAN, 0. H., PATEL, M., GAO, X. P., and RUBINSTEIN, I. Am. I PhysioL, 1998, 275 (1 Pt 2), R56—R62.
  • Vitamin E improves the uptake of unsaturated soya lecithin liposomes by human fibroblasts in vitro. BERROCAL, M. C., BUJAN, J., JURADO, F., and ABEGER, A. J. MicroencapsuL, 1998, 15 (3), 347–359.
  • Water soluble polymers for immunoisolation. II. Evaluation of multicomponent microen-capsulation systems. PROKOP, A., HUNKELER, D., POWERS, A. C., and WHITESELL, R. R. Adv. Polym. Sci., 1998, 136 (Microencapsulaticn, Microgels, Iniferters), 53–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.